Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q3

3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥134.5bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥126.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥5.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥6.8bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥6.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.1bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥6.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥7.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥115.9bnat 2023-12-31Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥105.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥64.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥51.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥47.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥23.2bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥101.472023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.642023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥112.572022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.432022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio44.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio44.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.7bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥76m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥7.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥11.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥11.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥296m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥884m
—segment totalrevenue2023-04-01 → 2023-12-31¥134.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥134.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥373m
—segment totalsegment profit2023-04-01 → 2023-12-31¥8.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥2.6bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥115.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥115.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥66m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥11.1bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥250m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
—segment totalrevenue2022-04-01 → 2022-12-31¥126.4bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥126.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥317m
—segment totalsegment profit2022-04-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Ordinary incomePrior1YTDDuration7094000000JPY
Ordinary incomeCurrentYTDDuration6523000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration6000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration47000000JPY
Gain on negative goodwill eiPrior1YTDDuration－JPY
Gain on negative goodwill eiCurrentYTDDuration25000000JPY
Extraordinary incomePrior1YTDDuration6000000JPY
Extraordinary incomeCurrentYTDDuration72000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration29000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration17000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration3000000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration13000000JPY
Loss on withdrawal from employees pension fund elPrior1YTDDuration－JPY
Loss on withdrawal from employees pension fund elCurrentYTDDuration38000000JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration1000000JPY
Extraordinary lossPrior1YTDDuration33000000JPY
Extraordinary lossCurrentYTDDuration71000000JPY
Income before income taxesPrior1YTDDuration7068000000JPY
Income before income taxesCurrentYTDDuration6524000000JPY
Income taxesPrior1YTDDuration2908000000JPY
Income taxesCurrentYTDDuration2753000000JPY
Profit lossPrior1YTDDuration4159000000JPY
Profit lossCurrentYTDDuration3771000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-3000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration4158000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration3774000000JPY
Profit lossPrior1YTDDuration4159000000JPY
Profit lossCurrentYTDDuration3771000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration0JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration9000000JPY
Other comprehensive incomePrior1YTDDuration0JPY
Other comprehensive incomeCurrentYTDDuration9000000JPY
Comprehensive incomePrior1YTDDuration4160000000JPY
Comprehensive incomeCurrentYTDDuration3780000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration4158000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3783000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-3000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember115286000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember10814000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember126101000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration126101000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember66000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember250000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember317000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-317000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass